MusclePharm recently sponsored Jake Shields, who won his UFC debut, but struggled to get it, pulling off a split decision over Martin Kampmann. Shields seemed to be completely gassed by the middle of the second round and struggled to do much in the final seven or eight minutes.
But judges had it 30-27 and 29-28 for Shields and 29-28 for Kampmann, apparently qualifying Shields for a shot at the winner of the welterweight title bout at UFC 124 on Dec. 11 between champion Georges St. Pierre and Josh Koscheck. Yahoo! Sports' Kevin Iole, Dave Doyle and Dave Meltzer all had it 29-28 Kampmann. Kampmann never let his hands go, and that may have hurt him with the judges.
Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that developments and manufacturers a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. MusclePharm's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen.
Johnson Controls (NYSE:JCI) ranked No. 14 of America's 500 largest corporations by Newsweek's Green Rankings. Johnson Controls placed second in its sector of consumer products and cars. Each company was given a Green Score, which is calculated using three component scores: Environmental Impact Score, Green Policies Score and Reputation Score. Johnson Controls' Green Score was 90.94 out of 100.
Johnson Controls is a global diversified technology and industrial leader serving customers in over 150 countries. Johnson Controls' 130,000 employees create quality products, services and solutions to optimize energy and operational efficiencies of buildings; lead-acid automotive batteries and advanced batteries for hybrid and electric vehicles; and interior systems for automobiles
Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global outdoor recreation company, previously released higher earnings and increased net sales for its third fiscal quarter ended July 2, 2010. Total net sales for the quarter were $124.0 million compared to $114.9 million in the prior year period. Net income of $10.4 million, or $1.09 per diluted share, compared favorably to net income of $9.0 million, or $0.97 per diluted share, in the same quarter last year.
Johnson Outdoors is a leading global outdoor recreation company that turns ideas into adventure with innovative, top-quality products. Johnson Outdoors designs, manufactures and markets a portfolio of winning, consumer-preferred brands across four categories: Watercraft, Marine Electronics, Diving and Outdoor Equipment.
The Jones Group Inc. (NYSE:JNY) is scheduled to release third quarter 2010 financial results on Wednesday, October 27, 2010. The Jones Group will host a conference call with management at 8:30 am eastern time. To participate in the call, please dial 412-858-4600.
The conference call will be webcast and made available through The Jones Group's website at www.jonesgroupinc.com. The call will also be recorded and made available through November 4, 2010. The recorded call may be accessed by dialing 877-344-7529 and entering account number 445285.
The Jones Group Inc. is a leading global designer, marketer and wholesaler of over 35 lifestyle brands with best-in-class product expertise across five divisions: apparel, footwear, jeanswear, jewelry and handbags. The Jones Group has a reputation for innovation, excellence in product quality and value, operational execution and talent.
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, released that Power3 Medical Products delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3 Medical Products' diagnostic test, and focused on Power3 Medical Products' Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).